Found 381 results
Journal Article
Broemeling A, Kerluke K, Black CD, Peterson S, MacDonald A, McKendry R. Developing and Maintaining a Population Research Registry to Support Primary Healthcare Research. Healthcare Policy Special Issue. 2009;5.
Wang ST, Bhattacharyya O, Wang B, Liu L, Chen B. Developing a Performance Measurement Framework and Indicators for Community Health Service Facilities in Urban China. BMC Family Practice. 2010;11.
Law M, Kawasumi Y, Morgan SG. Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on Health Affairs. 2011;30(12):2338-2345.
Law M, Kawasumi Y, Morgan SG. Despite Law, Fewer Than One In Eight Completed Studies Of Drugs And Biologics Are Reported On Time On Clinical Trials. Health Affairs. 2011;30(12):2338-2345.
Sivananthan SN, Peterson S, Lavergne R, Barer ML, McGrail KM. Designation, diligence and drift: understanding laboratory expenditure increases in British Columbia, 1996/97 to 2005/06. BMC Health Services Research. 2012;12.
Lewis S, Baird P, Evans RG, Ghali WA, Wright CJ, Gibson E, et al. Dancing with the porcupine: rules for governing the university-industry relationship. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienneCMAJ. 2001;165(6):783-785.
Chamberlayne R, Green B, Barer ML, Hertzman C, Lawrence WJ, Sheps SB. Creating a population-based linked health database: a new resource for health services research. Canadian journal of public health.Revue canadienne de sante publiqueCan.J.Public Health. 1998;89(4):270-273.
Law M, Soumerai SB, Adams AS, Majumdar SR. Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid. Archives of Internal MedicineArch.Intern.Med.. 2009;169(21):1969-1974.
Law M, Soumerai SB, Adams AS, Majumdar SR. Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid. Archives of internal medicine. 2009;169(21):1969.
Morgan SG, Kennedy J. Cost-Related Prescription Nonadherence in the United States and Canada. Clinical Therapeutics. 2009;31(1):213-219.
Kratzer J, McGrail KM, Strumpf E, Law M. Cost-Control Mechanisms in Canadian Private Drug Plans. Healthcare Policy. 2013;9(1):35-43.
Morgan SG, Grootendorst P, Lexchin J, Cunningham C, Greyson D. The cost of drug development: a systematic review. Health Policy. 2011;100(1):4-17.
Barer ML. Controlling medical care costs in Canada. JAMA : the journal of the American Medical AssociationJAMA. 1991;265(18):2393-2394.
Evans RG, Lomas J, Barer ML, Labelle RJ, Fooks C, Stoddart GL, et al. Controlling health expenditures--the Canadian reality. The New England journal of medicineN.Engl.J.Med.. 1989;320(9):571-577.
Mustard CA, Mayer T, Black CD, Postl B. Continuity of pediatric ambulatory care in a universally insured population. PediatricsPediatrics. 1996;98(6 Pt 1):1028-1034.
Evans RG, Stoddart GL. Consuming research, producing policy? American Journal of Public HealthAm.J.Public Health. 2003;93(3):371-379.
Reid R, Evans RG, Barer ML, Sheps S, Kerluke K, McGrail KM, et al. Conspicuous consumption: characterizing high users of physician services in one Canadian province. Journal of health services research & policyJ.Health Serv.Res.Policy. 2003;8(4):215-224.
Morgan SG, Hanley G, Greyson D. Comparing tiered formularies and reference pricing policies: A systematic review. Open Medicine. 2009;3(3).
Watson D, Finlayson G, Jacobs P. Comparing apples to apples: the relative financial performance of Manitoba's acute care hospitals. Healthcare management forum / Canadian College of Health Service Executives = Forum gestion des soins de sante / College canadien des directeurs de services de santeHealthc.Manage.Forum. 2002;Suppl:39-46.
McMahon M, Morgan SG, Mitton C. The Common Drug Review: a NICE start for Canada? Health policy (Amsterdam, Netherlands)Health Policy. 2006;77(3):339-351.
Wong ST, Seago JA, Keane D, Grumbach K. College students' perceptions of their experiences: what do minority students think? The Journal of nursing educationJ.Nurs.Educ.. 2008;47(4):190-195.
Lander B, Hanley GE, Atkinson-Grosjean J. Clinician-scientists in Canada: barriers to career entry and progress. PloS onePLoS One. 2010;5(10):e13168.
Hanley G, Morgan SG. Chronic Catastrophes: Exploring the Concentration & Sustained Nature of Ambulatory Rx Drug Expenditures in the Population of BC. Social Science and Medicine. 2009.
Hanley GE, Morgan SG. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada. Social science & medicine (1982)Soc.Sci.Med.. 2009;68(5):919-924.
Miller AR, Lalonde CE, McGrail KM. Children's persistence with methylphenidate therapy: a population-based study. Canadian journal of psychiatry.Revue canadienne de psychiatrieCan.J.Psychiatry. 2004;49(11):761-768.